The upregulated expression of SIRT7 in hypertensive patients complicated by CAD might be attributed to its pro-inflammatory properties, which primarily modulate inflammatory responses via the NF-κB signaling pathway—a pivotal regulator of inflammation. Here, NFKB1 is linked to coronary artery disorder.